Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
St. Jude Children's Research Hospital
University of Washington
University College, London
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota